Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 1, 2015, Pages 62-73

  Manetti, Mirko ^a   Rosa, Irene ^a   Messerini, Luca ^a   Ibba Manneschi, Lidia ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

CD34; Colonic wall; Fibrosis; Immunohistochemistry; Interstitial cells of Cajal; Myofibroblasts; Telocytes; Ulcerative colitis

Indexed keywords

CASE CONTROL STUDY; COLON; FEMALE; FIBROSIS; HUMAN; INTERSTITIAL CELL OF CAJAL; INTESTINE MUCOSA; MALE; MIDDLE AGED; MYENTERIC PLEXUS; PATHOLOGY; ULCERATIVE COLITIS;

CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; FEMALE; FIBROSIS; HUMANS; INTERSTITIAL CELLS OF CAJAL; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MYENTERIC PLEXUS;

EID: 84921524976     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12457     Document Type: Article

References (54)

1. Maul J, Zeitz M. Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations. Langenbecks Arch Surg. 2012; 397: 1-10.
2. Rieder F, Fiocchi C. Intestinal fibrosis in inflammatory bowel disease - Current knowledge and future perspectives. J Crohns Colitis. 2008; 2: 279-90.
3. Latella G, Sferra R, Speca S, et al. Can we prevent, reduce or reverse intestinal fibrosis in IBD? Eur Rev Med Pharmacol Sci. 2013; 17: 1283-304.
4. Yamagata M, Mikami T, Tsuruta T, et al. Submucosal fibrosis and basic-fibroblast growth factor-positive neutrophils correlate with colonic stenosis in cases of ulcerative colitis. Digestion. 2011; 84: 12-21.
5. Gordon IO, Agrawal N, Goldblum JR, et al. Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem. Inflamm Bowel Dis. 2014; Doi:10.1097/MIB.0000000000000080.
6. Reddy SN, Bazzocchi G, Chan S, et al. Colonic motility and transit in health and ulcerative colitis. Gastroenterology. 1991; 101: 1289-97.
7. Quigley EM. What we have learned about colonic motility: normal and disturbed. Curr Opin Gastroenterol. 2010; 26: 53-60.
8. Bassotti G, Villanacci V, Mazzocchi A, et al. Colonic propulsive and postprandial motor activity in patients with ulcerative colitis in remission. Eur J Gastroenterol Hepatol. 2006; 18: 507-10.
9. Bernardini N, Segnani C, Ippolito C, et al. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis. J Cell Mol Med. 2012; 16: 318-27.
10. Bassotti G, Antonelli E, Villanacci V, et al. Gastrointestinal motility disorders in inflammatory bowel diseases. World J Gastroenterol. 2014; 20: 37-44.
11. Popescu LM, Faussone-Pellegrini MS. TELOCYTES - a case of serendipity: the winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal-Like Cells (ICLC) to TELOCYTES. J Cell Mol Med. 2010; 14: 729-40.
12. Faussone-Pellegrini MS, Popescu LM. Telocytes. Biomol Concepts. 2011; 2: 481-9.
13. Popescu LM, Nicolescu MI. Telocytes and stem cells. In: Goldenberg RCdS, de Campos Carvalho AC, editors. Resident stem cells and regenerative therapy. Oxford: Academic Press/Elsevier; 2013. pp. 205-31.
14. Pieri L, Vannucchi MG, Faussone-Pellegrini MS. Histochemical and ultrastructural characteristics of an interstitial cell type different from ICC and resident in the muscle coat of human gut. J Cell Mol Med. 2008; 12: 1944-55.
15. Vannucchi MG, Traini C, Manetti M, et al. Telocytes express PDGFRα in the human gastrointestinal tract. J Cell Mol Med. 2013; 17: 1099-108.
16. Bani D, Formigli L, Gherghiceanu M, et al. Telocytes as supporting cells for myocardial tissue organization in developing and adult heart. J Cell Mol Med. 2010; 14: 2531-8.
17. Zheng Y, Bai C, Wang X. Telocyte morphologies and potential roles in diseases. J Cell Physiol. 2012; 227: 2311-7.
18. Cretoiu SM, Cretoiu D, Marin A, et al. Telocytes: ultrastructural, immunohistochemical and electrophysiological characteristics in human myometrium. Reproduction. 2013; 145: 357-70.
19. Popescu LM, Gherghiceanu M, Cretoiu D, et al. The connective connection: interstitial cell of Cajal (ICC) and ICC-like cells establish synapses with immunoreactive cells. Electron microscope study in situ. J Cell Mol Med. 2005; 9: 714-30.
20. Manole CG, Cismasiu V, Gherghiceanu M, et al. Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J Cell Mol Med. 2011; 15: 2284-96.
21. Zheng Y, Zhang M, Qian M, et al. Genetic comparison of mouse lung telocytes with mesenchymal stem cells and fibroblasts. J Cell Mol Med. 2013; 17: 567-77.
22. Zheng Y, Cretoiu D, Yan G, et al. Comparative proteomic analysis of human lung telocytes with fibroblasts. J Cell Mol Med. 2014; 18: 568-89.
23. Sun X, Zheng M, Zhang M, et al. Differences in the expression of chromosome 1 genes between lung telocytes and other cells: mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells and lymphocytes. J Cell Mol Med. 2014; 18: 801-10.
24. Cismasiu VB, Radu E, Popescu LM. miR-193 expression differentiates telocytes from other stromal cells. J Cell Mol Med. 2011; 15: 1071-4.
25. Smythies J, Edelstein L. Telocytes, exosomes, gap junctions and the cytoskeleton: the makings of a primitive nervous system? Front Cell Neurosci. 2014; 7: 278.
26. Ceafalan L, Gherghiceanu M, Popescu LM, et al. Telocytes in human skin-are they involved in skin regeneration? J Cell Mol Med. 2012; 16: 1405-20.
27. Popescu LM. The Tandem: telocytes - stem cells. Int J Biol Biomed Eng. 2011; 5: 83-92.
28. Milia AF, Ruffo M, Manetti M, et al. Telocytes in Crohn's disease. J Cell Mol Med. 2013; 17: 1525-36.
29. Manetti M, Rosa I, Messerini L, et al. A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis. J Cell Mol Med. 2014; 18: 253-62.
30. Díaz-Flores L, Gutiérrez R, García MP, et al. CD34+ stromal cells/fibroblasts/fibrocytes/telocytes as a tissue reserve and a principal source of mesenchymal cells. Location, morphology, function and role in pathology. Histol Histopathol. 2014; 29: 831-70.
31. Hinz B, Phan SH, Thannickal VJ, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol. 2012; 180: 1340-55.
32. Rieder F, Fiocchi C. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science. Curr Opin Gastroenterol. 2008; 24: 462-8.
33. Rieder F, Brenmoehl J, Leeb S, et al. Wound healing and fibrosis in intestinal disease. Gut. 2007; 56: 130-9.
34. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012; 18: 1028-40.
35. Farrugia G. Interstitial cells of Cajal in health and disease. Neurogastroenterol Motil. 2008; 20: 54-63.
36. Li L, Lin M, Li L, et al. Renal telocytes contribute to the repair of ischemically injured renal tubules. J Cell Mol Med. 2014; 18: 1144-56.
37. Yang Y, Sun W, Wu SM, et al. Telocytes in human heart valves. J Cell Mol Med. 2014; 18: 759-65.
38. Zhao B, Liao Z, Chen S, et al. Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted cardiac function in rats. J Cell Mol Med. 2014; 18: 780-9.
39. Xiao J, Wang F, Liu Z, et al. Telocytes in liver: electron microscopic and immunofluorescent evidence. J Cell Mol Med. 2013; 17: 1537-42.
40. Chen X, Zheng Y, Manole CG, et al. Telocytes in human oesophagus. J Cell Mol Med. 2013; 17: 1506-12.
41. Zheng Y, Li H, Manole CG, et al. Telocytes in trachea and lungs. J Cell Mol Med. 2011; 15: 2262-8.
42. Popescu LM, Gherghiceanu M, Suciu LC, et al. Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res. 2011; 345: 391-403.
43. Faussone-Pellegrini MS, Bani D. Relationships between telocytes and cardiomyocytes during pre- and post-natal life. J Cell Mol Med. 2010; 14: 1061-3.
44. Cretoiu D, Cretoiu SM, Simionescu AA, et al. Telocytes, a distinct type of cell among the stromal cells present in the lamina propria of jejunum. Histol Histopathol. 2012; 27: 1067-78.
45. Cantarero Carmona I, Luesma Bartolomé MJ, Junquera Escribano C. Identification of telocytes in the lamina propria of rat duodenum: transmission electron microscopy. J Cell Mol Med. 2011; 15: 26-30.
46. Manetti M, Guiducci S, Ruffo M, et al. Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis. J Cell Mol Med. 2013; 17: 482-96.
47. Zhao B, Chen S, Liu J, et al. Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat. J Cell Mol Med. 2013; 17: 123-33.
48. Gherghiceanu M, Popescu LM. Cardiac telocytes - their junctions and functional implications. Cell Tissue Res. 2012; 348: 265-79.
49. Gherghiceanu M, Popescu LM. Heterocellular communication in the heart: electron tomography of telocyte-myocyte junctions. J Cell Mol Med. 2011; 15: 1005-11.
50. Rusu MC, Mirancea N, Manoiu VS, et al. Skin telocytes. Ann Anat. 2012; 194: 359-67.
51. Wood JD. Enteric nervous system: reflex, pattern generators and motility. Curr Opin Gastroenterol. 2008; 24: 149-58.
52. Ohlsson B, Veress B, Lindgren S, et al. Enteric ganglioneuritis and abnormal interstitial cells of Cajal: features of inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 721-6.
53. Streutker CJ, Huizinga JD, Campbell F, et al. Loss of CD117 (c-kit)- and CD34-positive ICC and associated CD34-positive fibroblasts defines a subpopulation of chronic intestinal pseudo-obstruction. Am J Surg Pathol. 2003; 27: 228-35.
54. Nakayama H, Enzan H, Miyazaki E, et al. Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma. J Clin Pathol. 2000; 53: 626-9.